The University of Warwick Library - WebBridge
Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer : ARTemis Trial
Annals of Oncology.
Sorry - based on the information provided, WebBridge cannot offer
If online access is not found this means that the Library's subscriptions do not cover access to the article.
You may still be able to access it online if there is an open access version available.
- Check availability in Library Search to confirm whether we have the print journal at
the Library or if we have online access to the journal but not for the year you required.
- When the Library has no access to a specific print or online article you can use Get it for me! to request a copy.